BioRem Company Insiders
| BRM Stock | CAD 3.00 0.02 0.67% |
BioRem employs about 4 people. The company is managed by 4 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Recap of BioRem's management performance can provide insight into the venture performance.
BioRem |
BioRem Management Team Effectiveness
The company has return on total asset (ROA) of 0.1461 % which means that it generated a profit of $0.1461 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.5968 %, meaning that it generated $0.5968 on every $100 dollars invested by stockholders. BioRem's management efficiency ratios could be used to measure how well BioRem manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to 0.1 in 2024. Return On Capital Employed is likely to climb to 0.32 in 2024. At this time, BioRem's Other Current Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 3.8 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 1.9 M in 2024.Common Stock Shares Outstanding is likely to climb to about 22.9 M in 2024, whereas Net Income Applicable To Common Shares is likely to drop slightly above 1.2 M in 2024.
BioRem Workforce Comparison
BioRem Inc is currently under evaluation in number of employees category among its peers. The total workforce of Industrials industry is currently estimated at about 400. BioRem adds roughly 0.0 in number of employees claiming only tiny portion of equities under Industrials industry.
BioRem Profit Margins
The company has Profit Margin (PM) of 0.11 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.34 | 0.279 |
|
|
BioRem Inc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. BioRem Inc Price Series Summation is a cross summation of BioRem price series and its benchmark/peer.
BioRem Notable Stakeholders
A BioRem stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BioRem often face trade-offs trying to please all of them. BioRem's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BioRem's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| PEng MBA | President CEO | Profile | |
| Douglas Newman | CFO, Secretary | Profile | |
| Dan Costello | Director Operations | Profile | |
| Mark Smit | Director Services | Profile |
About BioRem Management Performance
The success or failure of an entity such as BioRem Inc often depends on how effective the management is. BioRem management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BioRem management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BioRem management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.09 | 0.10 | |
| Return On Capital Employed | 0.30 | 0.32 | |
| Return On Assets | 0.09 | 0.10 | |
| Return On Equity | 0.32 | 0.34 |
Please note, the imprecision that can be found in BioRem's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioRem Inc. Check BioRem's Beneish M Score to see the likelihood of BioRem's management manipulating its earnings.
BioRem Workforce Analysis
Traditionally, organizations such as BioRem use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BioRem within its industry.BioRem Manpower Efficiency
Return on BioRem Manpower
| Revenue Per Employee | 6.3M | |
| Revenue Per Executive | 6.3M | |
| Net Income Per Employee | 544.8K | |
| Net Income Per Executive | 544.8K | |
| Working Capital Per Employee | 1.7M | |
| Working Capital Per Executive | 1.7M |
Additional Tools for BioRem Stock Analysis
When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.